UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
archaeology (13) 13
humans (11) 11
life sciences & biomedicine (11) 11
science & technology (11) 11
female (9) 9
middle aged (8) 8
adult (7) 7
aged (6) 6
male (6) 6
oncology (6) 6
mutation (5) 5
chemotherapy (4) 4
excavations (4) 4
medicine (4) 4
tumors (4) 4
animals (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biomarkers (3) 3
breast neoplasms - drug therapy (3) 3
cancer therapies (3) 3
colorectal cancer (3) 3
equipment for shipping (3) 3
original (3) 3
performing operations (3) 3
pharmacology (3) 3
radiation therapy (3) 3
related equipment (3) 3
risk factors (3) 3
ships or other waterborne vessels (3) 3
transporting (3) 3
treatment outcome (3) 3
adenocarcinoma - genetics (2) 2
aged, 80 and over (2) 2
analysis (2) 2
ancient world (2) 2
anthropology (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antiquities (2) 2
banganarti site (2) 2
biomedicine (2) 2
breast cancer (2) 2
cancer (2) 2
cancer research (2) 2
cellular biology (2) 2
cognition (2) 2
colorectal neoplasms - genetics (2) 2
cost-effectiveness analysis (2) 2
deoxyribonucleic acid--dna (2) 2
dna methylation (2) 2
general & internal medicine (2) 2
genetics (2) 2
genetics & heredity (2) 2
human genetics (2) 2
infusions, intravenous (2) 2
kaplan-meier estimate (2) 2
laboratory medicine (2) 2
lung cancer (2) 2
medicine, general & internal (2) 2
methods (2) 2
mice (2) 2
molecular medicine (2) 2
neoplasms (2) 2
nubia antiquities (2) 2
original paper (2) 2
original research article (2) 2
pharmacology & pharmacy (2) 2
pharmacotherapy (2) 2
pilot projects (2) 2
prognosis (2) 2
proto-oncogene proteins - genetics (2) 2
proto-oncogene proteins p21 (2) 2
radiotherapy (2) 2
ras proteins - genetics (2) 2
research (2) 2
sudan antiquities (2) 2
survival analysis (2) 2
usage (2) 2
5-fu (1) 1
[sdv.bc]life sciences [q-bio]/cellular biology (1) 1
[sdv]life sciences [q-bio] (1) 1
abridged index medicus (1) 1
adaptation, psychological (1) 1
adenocarcinoma (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - surgery (1) 1
adenocarcinoma - therapy (1) 1
altar casket (1) 1
amino acid sequence (1) 1
angina pectoris (1) 1
angina, stable - blood (1) 1
angina, stable - diagnostic imaging (1) 1
angina, stable - therapy (1) 1
angiography (1) 1
angioplasty, balloon, coronary - trends (1) 1
anthropological research (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antineoplastic agents, immunological (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
antineoplastic agents, immunological - adverse effects (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 21, pp. 2020 - 2031
Patients with advanced non–small-cell lung cancer with a PD-L1 expression level of 1% or more of tumor cells were randomly assigned to receive nivolumab plus... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Middle Aged | Carcinoma, Non-Small-Cell Lung - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ipilimumab - adverse effects | Nivolumab - adverse effects | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Agents, Immunological - adverse effects | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Ipilimumab - administration & dosage | Nivolumab - administration & dosage | Lung cancer, Non-small cell | Drug therapy | Patient outcomes | Ipilimumab | Testing | Small cell lung carcinoma | Lung cancer | Non-small cell lung carcinoma | Oncology | Cancer therapies | Chemotherapy | Immunotherapy | PD-L1 protein | Biomarkers | Clinical medicine | Mutation | Drug dosages | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus | B7-H1 Antigen | Carcinoma, Non-Small-Cell Lung | Antineoplastic Combined Chemotherapy Protocols | Cellular Biology | Lung Neoplasms | Life Sciences | Antineoplastic Agents, Immunological | Nivolumab
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2015, Volume 33, Issue 14, pp. 1564 - 1573
Journal Article
Antiquity, ISSN 0003-598X, 02/2020, Volume 94, Issue 373, pp. 164 - 178
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2017, Volume 21, Issue 1, pp. 6 - 15
Chemotherapy-induced cognitive deficits in patients with breast cancer, predominantly in attention and verbal memory, have been observed in numerous studies.... 
Neuroimaging | Chemotherapy | Breast cancer | Cognition | Medical imaging | breast cancer | cognition | Review Paper | chemotherapy | neuroimaging
Journal Article
Polish archaeology in the Mediterranean, ISSN 1234-5415, 02/2016, Volume XXIV, Issue 1, pp. 369 - 388
In the course of two seasons in 2012 and 2013 the team carried out excavations and research on the living quarters alongside the fortifications of Banganarti,... 
Journal Article
Polish archaeology in the Mediterranean, ISSN 1234-5415, 2015, Volume 1, Issue XXIV, pp. 369 - 388
...Banganarti and Selib in 2011/2012 and 2013 SUDAN BANGANAR TI AND SELIB IN 2011/2012 AND 2013 Bogdan Żurawski Institute of Mediterranean and Oriental Cultures... 
Archaeology | Cultural history | Ancient World
Journal Article
Etudes et Travaux, ISSN 0079-3566, 2013, Volume 26, Issue 2, pp. 773 - 793
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2020, Volume 38, Issue 15_suppl, pp. 9501 - 9501
9501 Background: NIVO + IPI was shown to improve overall survival (OS) and durability of response vs chemo in 1L advanced NSCLC in CheckMate 227 Part 1,... 
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2020, Volume 38, Issue 15_suppl, pp. 9500 - 9500
9500 Background: In the phase 3 CheckMate 227 Part 1 (NCT02477826; minimum follow-up, 29.3 mo), 1L NIVO + IPI significantly improved overall survival (OS) vs... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.